- SCPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
scPharmaceuticals (SCPH) 8-K22 Mar 22Commercial preparedness activities ramping up to support anticipated Q4 2022 launch of FUROSCIX, if approvedFinancial data
Company Profile